Evidence map›Paper›PMID 34863144›Full record

Trial reportBMC public health2021

At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study.

Emily J Ciccone, Donaldson F Conserve, Gaurav Dave, Christoph P Hornik, Marlena L Kuhn, Jessica L Herling, Michelle Song, Shani Alston, Lindsay Singler, Michael D Schmidt and 9 more

Erratum issuedOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Emily J CicconeDivision of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Donaldson F ConserveDepartment of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
Gaurav DaveDivision of General Medicine and Clinical Epidemiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Christoph P HornikDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Marlena L KuhnCenter for Health Equity Research, Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA.
Jessica L HerlingCenter for Health Equity Research, Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA.
Michelle SongCenter for Health Equity Research, Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA.
Shani AlstonDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Lindsay SinglerDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Michael D SchmidtOffice of Technology, DataRobot, Inc, Boston, MA, USA.
Aaron JonesDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.
Samuel BroderickDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Lisa M WruckDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Warren A KibbeDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.
Allison E AielloDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
Christopher W WoodsDepartments of Medicine and Pathology, Duke University School of Medicine, Durham, NC, USA.
Alan RichmondCommunity-Campus Partnerships for Health, Raleigh, NC, USA.
Michael Cohen-WolkowiezDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Giselle Corbie-SmithCenter for Health Equity Research, Department of Social Medicine, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. gcorbie@med.unc.edu.
University of North Carolina at Chapel Hill · USDuke University · USClinical Research Institute · USCommunity-Campus Partnerships for Health · USGeorge Washington University · US

Funding

RADx-UP SAY YES COVID Test Study (S4)U24MD016258 · NIMHD · DUKE UNIVERSITY · PI COHEN-WOLKOWIEZ, MICHAEL, DAVE, GAURAV J · 2020 to 2023
$116.7M
NIMHD NIH HHS 3U24MD016258-01S1NIMHD NIH HHS U24 MD016258
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve as a global health crisis. Although highly effective vaccines have been developed, non-pharmaceutical interventions remain critical to controlling disease transmission. One such intervention-rapid, at-home antigen self-testing-can ease the burden associated with facility-based testing programs and improve testing access in high-risk communities. However, its impact on SARS-CoV-2 community transmission has yet to be definitively evaluated, and the socio-behavioral aspects of testing in underserved populations remain unknown.

methodsAs part of the Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) program funded by the National Institutes of Health, we are implementing a public health intervention titled "Say Yes! COVID Test" (SYCT) involving at-home self-testing using a SARS-CoV-2 rapid antigen assay in North Carolina (Greenville, Pitt County) and Tennessee (Chattanooga City, Hamilton County). The intervention is supported by a multifaceted communication and community engagement strategy to ensure widespread awareness and uptake, particularly in marginalized communities. Participants receive test kits either through online orders or via local community distribution partners. To assess the impact of this intervention on SARS-CoV-2 transmission, we will conduct a non-randomized, ecological study using community-level outcomes. Specifically, we will evaluate trends in SARS-CoV-2 cases and hospitalizations, SARS-CoV-2 viral load in wastewater, and population mobility in each community before, during, and after the SYCT intervention. Individuals who choose to participate in SYCT will also have the option to enroll in an embedded prospective cohort substudy gathering participant-level data to evaluate behavioral determinants of at-home self-testing and socio-behavioral mechanisms of SARS-CoV-2 community transmission. DISCUSSION: This is the first large-scale, public health intervention implementing rapid, at-home SARS-CoV-2 self-testing in the United States. The program consists of a novel combination of an at-home testing program, a broad communications and community engagement strategy, an ecological study to assess impact, and a research substudy of the behavioral aspects of testing. The findings from the SYCT project will provide insights into innovative methods to mitigate viral transmission, advance the science of public health communications and community engagement, and evaluate emerging, novel assessments of community transmission of disease.

Indexed as

COVID-19SARS-CoV-2Cohort StudiesHumansPandemicsProspective StudiesPublic HealthCommunity engagementCOVID-19 pandemicHealth behaviorHealth equityNon-pharmaceutical interventionsPublic health initiativeSARS-CoV-2 antigen testing

Identifiers

PMID34863144
PMCPMC8642753
OpenAlexW4200386483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.